Jonathan Kwok, Chief Executive Officer & Co-Founder at Infinitopes, said: Using our integrated 'right targets, right vectors, right patients, right time' approach, we aim to address the unmet clinical ...

Elizabeth Eilertsen explains how she opened a practice that aims to put patients at ease and puts their needs first.

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...

Preclinical proof-of-concept data supports the potential of CD3 Switch-DARPin platform to activate and boost T cells in the presence of tumor ...

Lip problems, simply, have been impossible to treat. Dr. Martin Egen at Bern University Hospital "just changed that." ...

Regulating drug discovery and pharmaceutical manufacturing, the FDA ensures the safety and effectiveness of innovative ...

Ten presentations (three oral and seven posters) from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the European Society of Gene and Cell Therapy (ESGCT) 31st ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

According to a new study, cases of babesiosis rose by an average of 9% annually between 2015 and 2022, with nearly half of the affected individuals also co-infected with another tick-borne illness, ...

A collaborative study in neuroscience, spearheaded by a research team of the Hong Kong University of Science and Technology ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, announced a $76 million expansion of its ADC manufacturing ...